| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Pamela Stephenson is Chief Commercial Officer at IRON. Pamela Stephenson's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $6.6M at current prices.
The IRON filings lean toward selling, a net 8,668 shares.
Pamela Stephenson has 5 Form 4 filings on record from February 2024 to February 2026, all as Chief Commercial Officer at Disc Medicine (IRON), 2024–2026.
The 8 reported transactions were 3 stock awards, 3 option or other derivative awards and 2 open-market sales.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $519K.
The largest open-market sale was 5,531 shares of IRON at an average $62.86 on February 17, 2026, about $348K.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.